IDH1 Gene Mutation: Clinical Trials

3 trials for IDH1 Gene Mutation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting, 1 terminated. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 1, Recruiting 1, Terminated 1

Follow IDH1 Gene Mutation: new trials by email Literature Review of IDH1 Gene Mutation trials Research Report on IDH1 Gene Mutation

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
a New Treatment of Newly Diagnosed IDH1 Mutation Acute Myeloid Leukemia
Ivosidenib combined with venetoclax and azacitidine - Acute Myeloid Leukemia, IDH1 Gene Mutation
Phase 2RecruitingThe First Affiliated Hospital of Soochow University422025-06-012025-06-06
AG-120 in People With IDH1 Mutant Chondrosarcoma
AG-120 - Chondrosarcoma, Chondrosarcoma, Grade 2
Phase 2Active not recruitingMemorial Sloan Kettering Cancer Center62020-03-042026-04-23
Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis
Busulfan, Cyclophosphamide, Fludarabine - Anemia, ASXL1 Gene Mutation
Phase 2TerminatedUniversity of Utah62018-03-302022-05-05

Narrower conditions

Anemia (1)  ·  Chondrosarcoma (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma, Follicular (1)  ·  Multiple Myeloma (1)  ·  Primary Myelofibrosis (1)  ·  Thrombocytopenia (1)

Broader conditions

Hemic and Lymphatic Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Hematologic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Lymphoproliferative Disorders (2)  ·  Blood Platelet Disorders (1)  ·  Blood Protein Disorders (1)  ·  Bone Marrow Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Cytopenia (1)  ·  Hemorrhagic Disorders (1)  ·  Hemostatic Disorders (1)  ·  Leukemia (1)

Interventions

Azacitidine (1)  ·  Busulfan (1)  ·  Cyclophosphamide (1)  ·  Hematopoietic Stem Cell Transplantation (1)  ·  Stem Cell Transplantation (1)  ·  fludarabine (1)  ·  ivosidenib (1)  ·  venetoclax (1)

Sponsors

Memorial Sloan Kettering Cancer Center (1)  ·  The First Affiliated Hospital of Soochow University (1)  ·  University of Utah (1)

Countries

United States (2)  ·  China (1)

Top investigators

Catherine Lee, MD (1)  ·  Ciara M Kelly, MBBCh, BAO (1)

Results publications

PMID 38446419